Issues related to international and corporate tax reform.
Build Back Better Act - Issues related to the Orphan Drug Tax Credit Issues relating to Intellectual Property protections for Covid-19 treatments and vaccines.
S. 1435, the Affordable Prescriptions for Patients Act.
H.R. 2873, the Affordable Prescriptions for Patients Through Promoting Competition Act.
H.R. 2884, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act.
Issues related to intellectual property, data exclusivity, patent eligibility & patent law reform
S. 2428, the False Claims Amendments H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act.
H.R. 19 / S. 2164, the Lower Costs, More Cures Act.
H.R. 3749, To amend title XXVII of the Public Health Services Act to expand the availability of coverage for lunch cancer screenings without the imposition of cost sharing.
Issues related to Cures 2.0.
Issues related to drug pricing.
COVID-19 vaccine and therapy development.
Issues related to health equity and clinical trials
Build Back Better Reconciliation Bill 
Issues related to drug regulation & approval pathways
S.2911, Seniors Prescription Drug Relief Act
Issues related to value-based arrangements
Oncology Care Model / Oncology Care First
H.R. 1730/S. 670- Speeding Therapy Access Today Act; 
H.R. 483/S. 350 - Newborn Screening Saves Lives Act
Diverse and Equitable Participation in Clinical Trials Act Discussion Draft  
General issues related to orphan disease drugs; 
FDA modernization policy issues; 
Reauthorization of newborn screening programs;
Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients;
General issues related to diagnostics for patients with rare diseases
Cancer screening, diagnostics and treatment Issues related to Medicare Parts B and D pricing reform, H.R. 3684, S. 2327, Senate
S. 1971, the Chronic Kidney Disease Improvement in Research and Treatment Act.
Issues related to CMS rulemaking [CMS-4190-F3, CMS-2482-P2].

S. 2614, the NOVEL Act
Medicare Multi-Cancer Early Detection Screening Coverage; H.R. 1946; 
H.R. 5260 - Reduced Costs and Continued Cures Act; Build Back Better Act 
General issues related to patient access to rare disease therapies, Part B and Part D drugs;
Issues related to home infusion for Part B patients;
Value-based payment arrangements; 
Efforts to improve coding, coverage, and access for rare disease therapies; 
Issues related to low volume Diagnosis Related Groups (DRGs) and rare therapies; 
General issues related to telemedicine
Issues related to 340B Issues related to the 340B drug discount program.
Discussions related to an appropriations hold on funding for a 2014 FDA rule that would move package inserts (PI) from paper to digital form-e-labeling.
FY2022 Budget Resolution (S.Con.Res.14) and Budget Reconciliation (H.R.5376)
TAX - Taxation/Internal Revenue Code TRD - Trade (domestic/foreign) HCR - Health Issues MMM - Medicare/Medicaid PHA - Pharmacy
136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office
ASTRAZENECA PHARMACEUTICALS LP
1800 CONCORD PIKE, P.O. BOX 15437, WILMINGTON, DE, 19850, US
SUSIE AHN HELEN DWIGHT ELIZABETH BROOKS KATIE JONES SUSIE AHN AARON W HUNTER HELEN DWIGHT ELIZABETH BROOKS KATIE JONES HELEN DWIGHT AARON W HUNTER ELIZABETH BROOKS SUSIE AHN THADDEUS FLOOD KATIE JONES CAROLINE QUAT HELEN DWIGHT SUSIE AHN THADDEUS FLOOD AARON W HUNTER ELIZABETH BROOKS CAROLINE QUAT KATIE JONES HELEN DWIGHT SUSIE AHN AARON W HUNTER ELIZABETH BROOKS CAROLINE QUAT